PT  - JOURNAL ARTICLE
AU  - Lampert, Adam
TI  - Decentralized governance may lead to higher infection levels and sub-optimal releases of quarantines amid the COVID-19 pandemic
AID  - 10.1101/2020.05.20.20108167
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.20.20108167
4099  - http://medrxiv.org/content/early/2020/05/25/2020.05.20.20108167.short
4100  - http://medrxiv.org/content/early/2020/05/25/2020.05.20.20108167.full
AB  - The outbreak of the novel Coronavirus (COVID-19) has lead countries worldwide to administer quarantine policies. However, each country or state decides independently what mobility restrictions to administer within its borders, while aiming to maximize its own citizens’ welfare. In turn, since individuals travel between countries and states, at least during periods when quarantines are less restrictive, the policy in one country may ultimately affect the infection level in other countries. Therefore, major questions are whether the policy dictated by a decentralized government is efficient, and if not, how the governments can coordinate a better policy. Here, we focus on the decision regarding the timing of releasing the quarantines. We consider a game theory model in which each of two governments decides when to switch from a restrictive to a non-restrictive quarantine and vice versa. We used parameter values driven by the literature and publically available data. We show that, if travel is sufficiently frequent during the non-restrictive quarantine periods, then the strategies are sub-optimal: Each governor tends to release the quarantine sooner, which ultimately leads to longer periods of restrictive quarantines and a higher prevalence of the disease. In turn, if the governments restrict international and interstate travel to a low level even when the quarantines are non-restrictive, the policy dictated by the decentralized governance may become optimal.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundings to declareAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSome parameter values are taken from estimates in the literature and some are estimated from publically available datasets (see Method: Parameterization). All the data and parameter values needed to regenerate the results shown in the figures are given in Methods.